TITLE

IS OESOPHAGEAL DILATATION A DYING SKILL? THE IMPACT OF PROTON PUMP INHIBITORS

AUTHOR(S)
Berry, P.A.; McNeil, N.I.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA72
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The number of endoscopic oesophageal dilatations performed for benign stricture was observed to have decreased in our unit over the past decade, making it hard for trainees to gain experience. This trend was investigated, and compared to the rise in the use of proton pump inhibitors (PPIs). Comparison was also made with the number of duodenal ulcers diagnosed each year. The number oF dilatations performed and new duodenal ulcers identified per year was obtained from records kept in the endoscopy unit for the years 1994 to 2001. As dilatations had been performed on several patients a number of times in quick succession, the number of different patients treated per year was used. Detailed information concerning the quarterly expenditure on all PPIs by the local health authority (Ealing, Hounslow and Hammersmith) was also obtained. Annual expenditure on PPIs rose steadily during the decade, from 1 630 000 in 1994 to 3 200 000 in 2001. The total number of endoscopic procedures remained broadly constant. The number of patients requiring dilatation fell. Only 4 patients presented in 2001, compared to 20 in 1994. The incidence of duodenal ulcer also fell, the trend being most marked in the latter part of the study period (96 in 1997, 59 in 2000). There was strong negative correlation between the amount spent by the health authority on PPIs and the number of dilatations performed (r = 0.68, p < 0.05). Between expenditure on PPIs and number of DUs identified there was less strong negative correlation (r = -0.50, p < 0.05). The reduction in the number of patients requiring dilatation over the past 10 years appears dramatic and sustained. This may be due to the rise in the prescription of powerful acid suppressants. Dilatation of benign oesophageal stricture may become increasingly rare, and trainee endoscopists may lack adequate practise in the technique.
ACCESSION #
9747767

 

Related Articles

  • Dyspepsia management in the millennium: to test and treat or not? Delaney, B.C. // Gut;Jan2003, Vol. 52 Issue 1, p10 

    Examines the cost effectiveness of testing and treating uninvestigated dyspepsia with endoscopy for non-responders compared with empiric proton pump inhibitor (PPI) treatment followed by endoscopy, or with strategies of test and treat followed by empiric PPI, with endoscopy reserved for...

  • To Establish the Efficacy of PPI Therapy for Ulcer Bleeding in the United States, Do We Need More Patients or More PPIs? Leontiadis, Grigoris I.; Howden, Colin W. // American Journal of Gastroenterology;Sep2006, Vol. 101 Issue 9, p2000 

    Proton pump inhibitor (PPI) therapy is widely used in the management of patients with ulcer bleeding. However, most randomized controlled trials (RCTs) have been conducted outside of the United States. Jensen and colleagues have conducted the first United States-based RCT to compare a PPI with...

  • A Cost-Effectiveness Analysis of Prescribing Strategies in the Management of Gastroesophageal Reflux Disease. Gerson, Lauren B.; Robbins, Anthony S.; Garber, Alan; Hornberger, John; Triadafilopoulos, George // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p395 

    OBJECTIVE: Patients who have uncomplicated gastroesophageal- reflux disease (GERD) typically present with heartburn and acid regurgitation. We sought to determine the cost-effectiveness of H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs) as first-line empiric therapy for...

  • BARRETT'S OESOPHAGUS—IS SURVEILLANCE REQUIRED? Gupta, S.; Fernandez, C.; Arnaout, A.; Theodossi, A.; Mendall, M.A. // Gut;Apr2003 Supplement 1, Vol. 52, pA43 

    Introduction: Controversy exists about the utility of a screening endoscopy programme and the value of proton pump inhibitors (PPI) in preventing the progression from metaplasia to dysplasia to cancer in Barrett's oesophagus (BO). Earlier studies to determine the risk of oesophageal...

  • Intravenous omeprazole acts more rapidly in H. pylori positve patients with peptic ulcer bleeding. Leodolter, A.; Glasbrenner, B.; Peitz, U.; Treiber, G.; Kahl, S.; Malfertheiner, P. // Gut;Sep2002 Supplement 2, Vol. 51, pA94 

    Intravenous proton pump inhibitor (PPI) therapy is the standard medical therapy in conjunction with endoscopic intervention for patients with peptic ulcer bleeding. PPI's are more effective in H. pylori positive patients, but up to now this effect has been observed following an extended period...

  • Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. Barkun, Alan; Bardou, Marc; Marshall, John K. // Annals of Internal Medicine;11/18/2003, Vol. 139 Issue 10, p843 

    Background: The management of patients with acute nonvariceal upper gastrointestinal bleeding has evolved substantially over the past 10 years amid a paucity of published consensus guidelines. Purpose: To provide evidence-based management recommendations that address clinically relevant issues....

  • Treatment of Nonvariceal Upper GI Hemorrhage: What's Happening in the Real World. Laine, Loren // American Journal of Gastroenterology;Jul2004, Vol. 99 Issue 7, p1247 

    Focuses on the establishment of therapy for most patients with nonvariceal upper gastrointestinal bleeding based on a number of randomized controlled trials; Beneficial effect of endoscopic therapy in patients with actively bleeding Mallory-Weiss tears; Effectiveness of bolus intravenous...

  • Gastroesophageal Reflux after Vertical Banded Gastroplasty is Alleviated by Conversion to Gastric Bypass. Ekelund, M.; Öberg, S.; Peterli, R.; Frederiksen, S.; Hedenbro, J. // Obesity Surgery;Jun2012, Vol. 22 Issue 6, p851 

    Background: Conversion operations after vertical banded gastroplasty (VBG) are sometimes performed because of vomiting and/or acid regurgitation. Primary operation with gastric bypass (GBP) is known to reduce gastroesophageal reflux (GERD). Previous studies have not been designed to...

  • Test for GERD Reveals That Many Are Taking Medications Unnecessarily.  // Women's Health Advisor;Sep2013, Vol. 17 Issue 9, p5 

    The article focuses on the increased inappropriate use of proton pump inhibitors (PPI) by people without being diagnosed with gastro esophageal reflux disease (GERD). It suggests for early diagnosis of GERD by esophageal power of hydrogen (Ph) monitoring following an endoscopy which helps to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics